Profil
Ranjan Batra currently works at Dyne Therapeutics, Inc., as Chief Scientific Officer from 2025 and Lexeo Therapeutics, Inc., as Vice President-Research & Translation.
Dr. Batra also formerly worked at Locanabio, Inc., as SVP-Research & Development.
Dr. Batra received his doctorate degree from the University of Florida.
Aktive Positionen von Ranjan Batra
| Unternehmen | Position | Beginn |
|---|---|---|
| DYNE THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 28.04.2025 |
Ehemalige bekannte Positionen von Ranjan Batra
| Unternehmen | Position | Ende |
|---|---|---|
| LEXEO THERAPEUTICS, INC. | Corporate Officer/Principal | 02.04.2025 |
Locanabio, Inc.
Locanabio, Inc. Packaged SoftwareTechnology Services Develops and operates software platform for addressing a wide spectrum of human genetic diseases | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Ranjan Batra
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
University of Florida
University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to treat muscle diseases | Health Technology |
Locanabio, Inc.
Locanabio, Inc. Packaged SoftwareTechnology Services Develops and operates software platform for addressing a wide spectrum of human genetic diseases | Technology Services |
Lexeo Therapeutics Inc
Lexeo Therapeutics Inc BiotechnologyHealth Technology Develops gene therapy to treat genetic diseases | Health Technology |
















